Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients.
Publication/Presentation Date
7-1-2021
Abstract
Five cases of axillary lymphadenopathy are presented, which occurred after COVID-19 vaccination and mimicked metastasis in a vulnerable oncologic patient group. Initial radiologic diagnosis raised concerns for metastasis. However, further investigation revealed that patients received COVID-19 vaccinations in the ipsilateral arm prior to imaging. In two cases, lymph node biopsy results confirmed vaccination-related reactive lymphadenopathy. Ipsilateral axillary swelling or lymphadenopathy was reported based on symptoms and physical examination in COVID-19 vaccine trials. Knowledge of the potential for COVID-19 vaccine-related ipsilateral adenopathy is necessary to avoid unnecessary biopsy and change in therapy. © RSNA, 2021.
Volume
300
Issue
1
First Page
296
Last Page
296
ISSN
1527-1315
Published In/Presented At
Özütemiz, C., Krystosek, L. A., Church, A. L., Chauhan, A., Ellermann, J. M., Domingo-Musibay, E., & Steinberger, D. (2021). Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients. Radiology, 300(1), E296–E300. https://doi.org/10.1148/radiol.2021210275
Disciplines
Diagnosis | Medicine and Health Sciences | Other Analytical, Diagnostic and Therapeutic Techniques and Equipment | Radiology
PubMedID
33625300
Department(s)
Department of Radiology and Diagnostic Medical Imaging
Document Type
Article